Scientific Sessions 2025  /  Cardiovascular Precision Therapy is at the Bedside  /  Navigating the Gene Therapy Frontier: Risks, Rewards, and Patient Safety
Logo

American Heart Association

  39
  0

Final ID:

Navigating the Gene Therapy Frontier: Risks, Rewards, and Patient Safety

  • Mcnally, Elizabeth  ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )
  • Rossano, Joseph  ( Childrens Hospital of Philadelphia , Bryn Mawr , Pennsylvania , United States )
    • Author Disclosures:
    Elizabeth McNally: DO have relevant financial relationships ; Consultant:Tenaya Therapeutics:Past (completed) ; Other (please indicate in the box next to the company name):Novartis:Active (exists now) ; Consultant:PepGene:Active (exists now) | Joseph Rossano: DO have relevant financial relationships ; Consultant:AskBio:Active (exists now) ; Consultant:Merck:Active (exists now) ; Consultant:CRI Biotech:Past (completed) ; Consultant:Bristol Myers Squibb:Active (exists now) ; Consultant:Bayer:Active (exists now) ; Consultant:Astellas:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiovascular Precision Therapy is at the Bedside

Monday, 11/10/2025 , 03:15PM - 04:30PM

Main Event

More abstracts on this topic:
CRISPR, RNA, and the Fight Against Cardiac Amyloidosis

Alexander Kevin, Arora Pankaj

Hyperlipidemia's Game-Changer: Can We Cure It with One Shot?

Rodriguez Fatima, Knowles Josh, Cuchel Marina

More abstracts from these authors:
Gene Therapy for Rare Cardiovascular Diseases

Mcnally Elizabeth, Bursac Nenad

The JCI

Mcnally Elizabeth

You have to be authorized to contact abstract author. Please, Login
Not Available